[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HU198694B - Process for producing azol derivatives and pharmaceutical compositions containing them as active components - Google Patents

Process for producing azol derivatives and pharmaceutical compositions containing them as active components Download PDF

Info

Publication number
HU198694B
HU198694B HU875414A HU541487A HU198694B HU 198694 B HU198694 B HU 198694B HU 875414 A HU875414 A HU 875414A HU 541487 A HU541487 A HU 541487A HU 198694 B HU198694 B HU 198694B
Authority
HU
Hungary
Prior art keywords
formula
compound
phenyl
chlorophenyl
compounds
Prior art date
Application number
HU875414A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT45506A (en
Inventor
Helmut Egger
Rudolf Waechli
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUT45506A publication Critical patent/HUT45506A/hu
Publication of HU198694B publication Critical patent/HU198694B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU875414A 1986-12-03 1987-12-02 Process for producing azol derivatives and pharmaceutical compositions containing them as active components HU198694B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3641320 1986-12-03

Publications (2)

Publication Number Publication Date
HUT45506A HUT45506A (en) 1988-07-28
HU198694B true HU198694B (en) 1989-11-28

Family

ID=6315380

Family Applications (1)

Application Number Title Priority Date Filing Date
HU875414A HU198694B (en) 1986-12-03 1987-12-02 Process for producing azol derivatives and pharmaceutical compositions containing them as active components

Country Status (24)

Country Link
JP (1) JPH0678318B2 (xx)
KR (1) KR880007481A (xx)
AT (1) AT395587B (xx)
AU (1) AU605522B2 (xx)
BE (1) BE1001235A4 (xx)
CH (1) CH677925A5 (xx)
DK (1) DK631287A (xx)
ES (1) ES2010235A6 (xx)
FI (1) FI875300A (xx)
FR (1) FR2607810B1 (xx)
GB (1) GB2199579B (xx)
GR (1) GR871897B (xx)
HU (1) HU198694B (xx)
IL (1) IL84665A (xx)
IT (1) IT1211944B (xx)
LU (1) LU87063A1 (xx)
MY (1) MY103004A (xx)
NL (1) NL8702897A (xx)
NZ (1) NZ222765A (xx)
PH (1) PH24666A (xx)
PL (1) PL151588B1 (xx)
PT (1) PT86255B (xx)
SE (1) SE8704792L (xx)
ZA (1) ZA879093B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814277D0 (en) * 1988-06-16 1988-07-20 Glaxo Group Ltd Chemical compounds
TW225526B (xx) * 1991-09-02 1994-06-21 Yamanouchi Pharma Co Ltd
GB9409882D0 (en) * 1994-05-18 1994-07-06 Sandoz Ltd Organic compounds
GB0128415D0 (en) * 2001-11-27 2002-01-16 Univ Sheffield Medicaments

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT382868B (de) * 1983-03-11 1987-04-27 Sandoz Ag Verfahren zur herstellung neuer azolderivate und deren salze
JPH0625144B2 (ja) * 1986-02-24 1994-04-06 四国化成工業株式会社 新規イミダゾール化合物及び該化合物の合成方法

Also Published As

Publication number Publication date
AU605522B2 (en) 1991-01-17
DK631287A (da) 1988-06-04
NL8702897A (nl) 1988-07-01
NZ222765A (en) 1990-11-27
GB2199579B (en) 1990-07-18
IL84665A0 (en) 1988-05-31
HUT45506A (en) 1988-07-28
PT86255B (pt) 1990-11-07
IT1211944B (it) 1989-11-08
FR2607810B1 (fr) 1989-12-01
IT8748656A0 (it) 1987-12-01
GB8727978D0 (en) 1988-01-06
FR2607810A1 (fr) 1988-06-10
KR880007481A (ko) 1988-08-27
MY103004A (en) 1993-03-31
JPH0678318B2 (ja) 1994-10-05
FI875300A0 (fi) 1987-12-01
SE8704792D0 (sv) 1987-12-01
CH677925A5 (xx) 1991-07-15
DK631287D0 (da) 1987-12-01
GB2199579A (en) 1988-07-13
PL269180A1 (en) 1988-08-18
SE8704792L (sv) 1988-06-04
GR871897B (en) 1988-04-04
FI875300A (fi) 1988-06-04
PH24666A (en) 1990-09-07
PL151588B1 (en) 1990-09-28
IL84665A (en) 1991-11-21
BE1001235A4 (fr) 1989-08-29
ATA316887A (de) 1992-06-15
PT86255A (en) 1988-06-01
ES2010235A6 (es) 1989-11-01
AT395587B (de) 1993-01-25
LU87063A1 (fr) 1988-07-14
AU8196287A (en) 1988-06-16
JPS63145270A (ja) 1988-06-17
ZA879093B (en) 1989-07-26

Similar Documents

Publication Publication Date Title
FI71929C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara eterfoereningar samt vid deras framstaellning anvaendbara mellanprodukter.
SK277923B6 (en) 3-imidazolymethyl-1,2,3,9-tetrahydro-4h-carbazole-4-on derivatives, method of their preparation and pharmaceutical agents containing this agents
JPH082871B2 (ja) ピペラジニルカンファースルフォニルオキシトシン拮抗物質の置換アミン誘導体
HU194839B (en) Process for production of derivatives of triasole and imidasole and medical preparatives containing such compounds
BR112012007828B1 (pt) compostos inibidores da xantina oxidase, processo para preparar os compostos, e, composição farmacêutica para a inibição da xantina oxidase
JPH082870B2 (ja) ピペラジニルカンファースルフォニルオキシトシン拮抗物質の置換誘導体
JP2003516400A (ja) ヒドロキシルスチルベンならびに新規スチルベン誘導体および類似体による抗炎症治療および乾癬治療ならびにプロテインキナーゼ阻害
HU194873B (en) Process for producing 2-indolinone derivatives
JP3133432B2 (ja) フッ素化合物
US4921856A (en) Dihydropyridazinone derivatives, a process for their preparation and pharmaceutical preparations containing these compounds
JP3207417B2 (ja) シクロアルキレンアゾール、その製造、これを有する製剤並びに医薬品の製造のためのその使用
US4609666A (en) Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
HU198694B (en) Process for producing azol derivatives and pharmaceutical compositions containing them as active components
FR2536398A1 (fr) Nouveaux composes heterocycliques
US4036983A (en) Ferrocene compounds and pharmaceutical composition for use in treatment of iron deficiency in an animal
EP0106251B1 (en) Pyrazolidinedione derivative having vasodilating, antiaggregating and hypocholesterolemic activities
JPS5883620A (ja) 薬剤としての4−フエニル−4−オキソ−2−ブテン酸のある種の誘導体及びそれを含有する組成物
JPH082872B2 (ja) ピペラジニルカンファースルフォニルオキシトシン拮抗物質の置換アルキル誘導体
EP0155523A1 (en) 3-Amino-1-(4,5,6,7-Tetrahydro-benzothiazolyl)-2-Pyrazolines,a process for their preparation and pharmaceutical products containing these compounds
HU201082B (en) Enolethers of 6-chloro-4-hydroxy-2-methyl-N-(2-pyridyl)-2H-thieno(2,3-e)-1,2-thiazin-3-carboxylic acid amide-1,1-dioxide, a process for their preparation and their use.
US4614743A (en) Methods of treating pain and inflammation with 4,7-dimethyl-2-(4-pyridinyl)-1,2,4,-triazolo[1,5-a]pyrimidin-5(4H)-one or the pharmaceutically acceptable salts or solvates thereof
IE43311B1 (en) 1-methyl-2-(pyridyloxmyethyl)-5-nitroimidazoles and process for preparing them
CA1096860A (en) Imidazole derivatives
JPH06172365A (ja) 10−チアイソアロキサジン誘導体およびその用途
IE51776B1 (en) Indoleacetic acid derivatives,process for producing the same and pharmaceutical compositions comprising the same

Legal Events

Date Code Title Description
HU90 Patent valid on 900628